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Abstract
Background: The airway epithelium is thought to play an important role in the pathogenesis of asthmatic disease.
However, much of our understanding of airway epithelial cell function in asthma has been derived from in vitro
studies that may not accurately reflect the interactive cellular and molecular pathways active between different
tissue constituents in vivo.
Methods: Using a sheep model of allergic asthma, tracheal explants from normal sheep and allergic sheep
exposed to house dust mite (HDM) allergen were established to investigate airway mucosal responses ex vivo.
Explants were cultured for up to 48 h and tissues were stained to identify apoptotic cells, goblet cells, mast cells
and eosinophils. The release of cytokines (IL-1a, IL-6 and TNF-a) by cultured tracheal explants, was assessed by
ELISA.
Results: The general morphology and epithelial structure of the tracheal explants was well maintained in culture
although evidence of advanced apoptosis within the mucosal layer was noted after culture for 48 h. The number
of alcian blue/PAS positive mucus-secreting cells within the epithelial layer was reduced in all cultured explants
compared with pre-cultured (0 h) explants, but the loss of staining was most evident in allergic tissues. Mast cell
and eosinophil numbers were elevated in the allergic tracheal tissues compared to naïve controls, and in the
allergic tissues there was a significant decline in mast cells after 24 h culture in the presence or absence of HDM
allergen. IL-6 was released by allergic tracheal explants in culture but was undetected in cultured control explants.
Conclusions: Sheep tracheal explants maintain characteristics of the airway mucosa that may not be replicated
when studying isolated cell populations in vitro. There were key differences identified in explants from allergic
compared to control airways and in their responses in culture for 24 h. Importantly, this study establishes the
potential for the application of tracheal explant cultures in relevant ex vivo investigations on the therapeutic and
mechanistic modalities of asthmatic disease.
Background
Asthma is a complex chronic inflammatory disease, the
hallmarks of which include damage to the airway epithe-
lium and underlying parenchyma, recruitment and acti-
vation of inflammatory cells, and airflow obstruction
associated with remodeling of the airways. The mucosal
epithelial layer of the airways plays a pivotal role in the
non-specific host defense of the respiratory tract and in
shaping both innate and adaptive immune responses of
the respiratory system [1,2]. In asthma, the hypertrophy
of submucosal glands and hyperplasia of goblet cells in
the airways [3] form the basis of excessive mucus
production, leading to sometimes fatal bronchial plug-
ging. Furthermore, many of the pathological features of
asthmatic tissues such as tissue injury and inflammation
are triggered in part by mediators derived from the air-
way epithelium [1,4].
In vitro cell-based studies have allowed detailed inves-
tigations of the molecular mechanisms underlying the
pathology of asthmatic disease. This has included stu-
dies in humans and appropriate animal models using
primary airway epithelial, fibroblast and smooth muscle
cells cultured from biopsy samples collected by fibreop-
tic bronchoscopy or post-mortem tissues [5,6]. However,
an inherent limitation of these in vitro investigations is
the inherent loss of tissue-specific cell differentiation
and tissue architecture that is associated with studying
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isolated cells, and particularly cells of epithelial origin
[6]. The development of more appropriate cell/tissue
culture systems for airway epithelial investigation, that
uses an air-liquid interface, has demonstrated differen-
tiation into mucus-secreting and ciliated cells that dis-
play key functional differences compared to cells grown
in submerged cultures [7,8]. In addition, the growth of
explant cultures established from tracheal tissues adds a
further dimension in providing the opportunity to exam-
ine ex vivo the interactions between epithelium and
underlying structural cells of the airway mucosa. Tra-
cheal explants established in sheep display many key
features of the in vivo airways such as mucus coverage,
mucociliary clearance and cell structure [9]. While such
studies have been used to examine approaches for gene
delivery [9-11] and mechanisms of epithelial cell mucus
secretion [12], none to date have used tracheal explants
to investigate the allergic basis of bronchial asthma. In
this study we use a validated model of human allergic
asthma [13-15] to investigate airway mucosal responses
ex vivo in tracheal explants derived from normal sheep
and allergic sheep exposed to house dust mite (HDM)
allergen.
Methods
Experimental sheep, allergen sensitization and
airway challenges
Female Merino-cross ewe lambs (4-5 months of age)
free of significant pulmonary disease [14] were used for
these studies. All experimental animal procedures and
the collection of tissues and cells were approved by the
Animal Ethics Committee of Monash University, follow-
ing guidelines set by the National Health and Medical
Research Council (NH&MRC) of Australia.
Sheep were sensitized by immunization with solubi-
lized HDM whole extract (Dermatophagoides pteronyssi-
nus), and immunized sheep were classed as allergic
when they showed increased HDM-specific serum IgE
levels as assessed by ELISA [14]. Naïve, control animals
were not immunized with HDM. All allergic sheep were
subsequently given 3 airway allergen challenges at
weekly intervals to prime the respiratory tract to HDM
allergen [16,17] and BAL samples were collected using a
fibre-optic bronchoscope to assess airway inflammation
[14]. The allergen challenges were followed by a rest
period of 2 weeks before all animals were euthanased
(barbituate overdose) for the collection of tracheal
tissues.
Preparation of tracheal explant cultures
Following resection, the trachea was cut longitudinal
along the midline through the trachealis, and pinned
open onto a dissecting board. The mucosa was dissected
gently away from cartilage and small 5 mm discs of
tracheal tissue were cut away using a biopsy punch (Kai
Medical, Germany). Tracheal explants were established
in culture as outlined previously [9], with some modifi-
cations. Briefly, sterile strips of filter paper (Whatman®
Grade 1; Sigma, Australia) pre-soaked in medium
(DMEM10; DMEM with 10% fetal bovine serum + peni-
cillin/streptomycin; Invitrogen, Life Technologies, Aus-
tralia) were placed across a 35 mm diameter culture
dish sitting within a larger 60 mm dish, to which 3 ml
DMEM10 was added. For each treatment, triplicate tra-
cheal biopsies were placed upon the strip of filter paper
set up within each plate.
To investigate possible changes in epithelial morphol-
ogy and tissue architecture, tracheal biopsies were col-
lected from control (naïve) sheep and explants prepared
in triplicate as detailed above. Following the application
of 5 μl of DMEM containing HDM allergen (10 μg/ml)
or 5 μl of control DMEM to the epithelial surface,
explants were cultured for a period of 5 h, 24 h or 48 h
at 37°C in 5%CO2/air. In a separate experiment, tracheal
tissues were resected from allergic and control (naïve)
sheep and tracheal explants established in triplicate cul-
tures for a 24 h period.
Tissue processing and histology
After culture, tracheal explants were transferred into a
small tube containing 100 μl DMEM10, briefly agitated
and (medium washout) samples stored at -20°C for later
cytokine analyses. Tissues were then fixed in 4% paraf-
ormaldehyde (PFA) and embedded in paraffin for histol-
ogy. Paraffin-embedded tracheal tissue explants were
sectioned (7 μm) and stained with hematoxylin and
eosin (H&E), alcian blue/periodic acid-schiff (AB/PAS)
or immunostained to identify caspase-3 positive apopto-
tic cells, mucosal mast cells and eosinophils.
Immunohistochemistry for caspase-3, mast cells and
eosinophils
Immunostaining for caspase-3 was used to identify
apoptotic cells [18] in tracheal tissues before and after 5
h, 24 h and 48 h in culture. Briefly, paraffin-embedded
PFA-fixed tissue sections were dewaxed, then rehydrated
and immersed in 0.1 M PBS containing 0.3% triton
X100 (PBS-TX) followed by 0.1 M citric acid buffer and
microwave treatment for antigen retrieval. Sections were
washed in PBS-TX, endogenous peroxidase activity
blocked upon incubation with 0.3% H2O2, again washed
and incubated with 5% normal goat serum (NGS)/2%
BSA in PBS-TX. Sections were then incubated with rab-
bit polyclonal anti-human/mouse activated caspase-3
antibody (Ab) (R&D Systems, USA), washed and incu-
bated with biotinylated goat anti-rabbit IgG (Cayman
Chemical, USA), and again washed prior to incubation
with streptavidin-horseradish peroxidase (HRP) complex
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(Amersham Biosciences, UK). Following washing, sec-
tions were developed with 3,3’-diaminobenzidine tetra-
hydrochloride (DAB; Sigma) and finally dehydrated and
cover-slipped with Depex™ tissue mounting fluid (Fluka
Biochemika, Switzerland).
For the detection of mast cells and eosinophils, paraf-
fin embedded tissue sections were blocked as above,
then incubated with 10% normal sheep serum in PBS
prior to application of primary antibodies. A polyclonal
rat anti-ovine tryptase Ab reactive with all ovine respira-
tory mast cells [19] was kindly provided by Professor
Hugh Miller, University of Edinburgh, UK. For eosino-
phil detection, the ovine eosinophil-specific mouse anti-
galectin-14 mAb (clone EL1.2) was used [20]. Following
incubations, sections were washed then incubated with
HRP-conjugated rabbit anti-rat Ig (Dako, Denmark) or
HRP anti-mouse (Dako) for the detection of mast cells
and eosinophils, respectively. This was followed by
further washes, then development in DAB as detailed
above. Slides were air-dried and lightly counterstained
with Wright’s stain (Sigma), then cover-slipped in
Depex™.
Cell counts
In AB/PAS stained sections, intensely purple staining
cells within the epithelium (goblet cells) were enumer-
ated in triplicate samples at 200× magnification using a
calibrated grid. All intact tissue was examined for each
treatment (maximum 15 microscopic fields) and counts
were expressed as cell number per mm length of
epithelium.
Caspase-3 positive cells, within the epithelial layer
only, were enumerated in triplicate samples at 200×
magnification using a calibrated grid. All intact tissue
was examined for each treatment (maximum 15 micro-
scopic fields) and counts were expressed as cell number
per mm length of epithelium.
For mast cell and eosinophil cell counts, immunoper-
oxidase positive cells in the lamina propria underlying
the epithelium were enumerated in triplicate samples at
200× magnification using a calibrated grid. All intact tis-
sue was examined for each treatment (maximum 15
microscopic fields) and counts were expressed as cell
number per mm2 area of lamina propria underlying the
epithelium. Cell counts for both mast cells and eosino-
phils were performed on cells that were densely stained.
Cells partially stained were classified as degranulated
and were not counted.
Detection of cytokines in tracheal washout samples
Tracheal explant washout samples were collected for
determination of the ovine cytokines IL-1a, IL-6 and
TNF-a by enzyme-linked immunosorbent assay
(ELISA), as described previously [21]. The minimum
detectable levels of IL-6 and TNF-a were 2.63 ng/ml
and 1.98 ng/ml, respectively.
Statistical analyses
Results are presented as means ± SEM. A Kruskal-
Wallis non-parametric test was used to compare treat-
ments, within experimental and control groups, and a
Dunn’s post-hoc test was used where significant. A
Mann-Whitney non-parametric test was used for com-
parisons between experimental and control groups. For
all statistical analyses, p < 0.05 was considered
significant.
Results
Priming of the airways with allergen induced a marked
recruitment of eosinophils (15-32% of BAL leukocytes)
into the BAL fluid when assessed at 48 h post-challenge,
similar to that observed in our previous studies [14,16].
Histological and functional changes in tracheal
explant cultures
Tracheal tissues were collected from control (naïve) ani-
mals to assess the effects of maintaining tracheal
explants in culture for 0 h, 5 h, 24 h, and 48 h. Exami-
nation of the explants under a dissecting microscope
throughout the culture period showed that the tracheal
epithelium appeared intact, with evidence of actively
beating cilia (not shown). This was supported in the his-
tological examination of tracheal explant tissue sections;
while there were several areas showing a less organised
arrangement of cells and a reduced number of ciliated
cells, there appeared to be little change in epithelial
structure and general integrity of the cultured mucosal
tissue compared to fresh pre-cultured (0 h) tissue (Fig-
ure 1A-D).
AB/PAS staining of sections revealed the presence of
mucus-producing goblet cells within the tracheal
explants. Positively stained goblet cells were seen in all
sections, with staining particularly prominent in the tra-
cheal epithelium prior to culture, followed by a dramatic
reduction in the level of staining throughout the culture
period (Figure 1E-H). Cell counts confirmed a rapid loss
or decline in AB/PAS reactive goblet cells over time in
both the media and HDM-treated tissue (Figure 2).
Immunostaining for caspase-3, a marker for cell apop-
tosis, was examined in paraffin sections of tracheal
explants from control animals before and after culture.
Caspase-3 staining of apoptotic bodies was seen in all
sections of cultured tissue and staining was evident
within the epithelium and underlying lamina propria
(Figure 1I-L). No positive staining within the epithelium
was seen in tissue at 0 h, while some staining was pre-
sent in the underlying lamina propria. Staining of apop-
totic cells was most prominent in tracheal explants
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cultured for 48 h when positive staining was seen in the
nucleus as well as the cytoplasm, with intense nuclear
staining representing more advanced apoptosis apparent
in the epithelium compared to the earlier time-points
(Figure 1I-L).
Comparison of tracheal explants established from
allergic and control tissues
Tracheal tissues were collected from allergic and control
(naïve) sheep. The airways of allergic animals had been
‘primed’ with three aerosolised HDM challenges, result-
ing in the induction of airway eosinophilia and raised
allergen-specific IgE levels in serum and bronchoalveolar
lavage (BAL), as noted previously [14]. Two weeks after
the last challenge, allergic and control animals were
sacrificed for the collection of tissues, and tracheal
explants were established in culture for a period of 24 h.
At 0 h there were intense, AB/PAS-stained goblet cells
in the epithelium as reported earlier (see Figure 1E-H),
and the mean number of goblet cells was greater in aller-
gic versus control epithelium (86.0 ± 6.1 vs 67.0 ± 13.9
cells/mm epithelium) although this difference was not
statistically significant. A dramatic loss in goblet cell
staining was observed after 24 h culture in medium alone
or in the presence of HDM allergen (Figure 3), with a sig-
nificantly greater percentage loss in allergic (86.9 ± 2.19)
compared to control (60.61 ± 8.50) tissues (Mann Whit-
ney; p = 0.036; percentage loss not shown in Figure).
Immunohistochemistry revealed that tracheal tryptase-
positive mast cells were distributed throughout the
lamina propria underlying the epithelium, but not loca-
lised within the epithelium (Figure 4A-B). Quantitation
of tissue mast cells showed that prior to explant culture
(0 h), mast cells were more numerous in allergic com-
pared to control tissues (Figure 5A; p < 0.05). Following
24 h culture in medium with or without HDM, there
was a significant loss of mast cell staining in the allergic
tracheal explants to levels similar to that seen in the
control tissues (Figure 5A). Large, diffusely-stained cells
were typically seen in the allergic explant tissues, com-
pared to smaller-stained mast cells in control tissues.
Galectin-14 positive eosinophils were localised mainly
beneath the epithelial basement membrane, and were
particularly prominent in allergic tissues (Figure 4C-D).
 0h         5h         24h          48h 
A             B        C         D 
E      F        G         H 
I      J        K         L 
Figure 1 Histology of tracheal tissues before and following culture ex vivo. (A-D) H&E stain demonstrating intact ciliated epithelium over a
48 h incubation period; little change in tissue integrity is seen at 48 h (D). (E-H) AB/PAS stain showing the presence of mucus-producing goblet
cells; strong staining is evident in pre-cultured tissue (E), while a progressive decrease in staining is seen following 48 h of culture (H). (I-L)
Caspase-3 immunostained sections demonstrating apoptosis; positive staining cells present in the epithelium and underlying tissue. Both
cytoplasmic and nuclear staining is seen, with more intense nuclear staining evident at 48 h (L) (original magnification ×200).
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Approximately five-fold greater eosinophil numbers
were seen in pre-cultured (0 h), and HDM-treated tissue
in allergic compared to control tissues (Figure 5B; p <
0.05). No change in eosinophil numbers was observed
after 24 h culture in the absence or presence of HDM.
Cytokine release by tracheal explants following
HDM stimulation
ELISAs were performed on tissue washout samples for
the soluble cytokines IL-1a, IL-6 and TNF-a. We were
unable to detect TNF-a or IL-1a in any of the washout
Figure 2 Kinetics of goblet cells in the epithelium of control tracheal explants over a period of 48 h in culture. Mean (± SEM) counts
(triplicate cultures from n = 3 naïve sheep) of AB/PAS-stained goblet cells within the tracheal epithelium from cultures grown in media alone or
in the presence of HDM allergen (* denotes statistical significance, p < 0.05; Kruskal-Wallis, comparison to 0 h pre-cultured tissue).
Figure 3 Goblet cell numbers before and after culture in tracheal explants from control and allergic tissues. AB/PAS positive cell counts
(mean of triplicate cultures ± SEM) per 0.5 mm of epithelium in tracheal explants before (0 h) and following (24 h) culture in the presence of
media alone or HDM. (* denotes statistical significance, p < 0.05, ***p < 0.001; Kruskal-Wallis).
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samples (data not shown), as they were below the detec-
tion limit for these assays.
IL-6 secretion was not detected in any of the control
tracheal tissues (< 2.65 ng/ml), but was clearly evident
in the washout samples from allergic tracheal explants
cultured for 24 h in the presence of media alone (4.08 ±
0.67 ng/ml) or with HDM allergen (3.71 ± 1.20 ng/ml;
not statistically significant).
Discussion
The use of in vitro models, in particular primary cell
cultures, has greatly contributed to our understanding of
molecular pathways in allergic inflammation. However,
asthma is a complex disease, and in vitro studies that
focus on isolated cell populations may not accurately
represent in vivo conditions where dynamic and com-
plex interactions take place between different structural
and inflammatory cells. Tissue explant cultures estab-
lished ex vivo have been used for a variety of applica-
tions, and while their use may be restricted to short-
term studies, they offer a distinct advantage in providing
a more complete tissue microenvironment for experi-
mentation that preserves many of the in vivo tissue
characteristics. Previous studies in sheep have reported
the use of tracheal explants for cystic fibrosis research
[9,11]. The present study used a relevant large animal
model of human asthma to establish for the first time
an ex vivo tracheal explant model as an investigative
tool for asthma research.
We demonstrate in the present study that, other than
the dramatic loss of goblet cell numbers, which likely
reflects a tissue response to the new (ex vivo) conditions
rather than being solely indicative of tissue injury and
cell death, the epithelial structure and general morphol-
ogy of cultured tracheal explants was maintained for up
to 48 h in culture. This is in agreement with an earlier
study using this model system which reported that
explants maintained over this period in culture clearly
display cilia and microvilli (as assessed by scanning elec-
tron microscopy and light microscopy) as well as ciliary
beating, retain normal barrier functions including muco-
ciliary clearance and mucus production, and an intact
cellular structure [9]. It should be noted that in the pre-
sent study, however, apoptosis within the tracheal
epithelium was already observed after 5 h in culture
and, while there was no further increase in the degree
of apoptosis with culture time, intense caspase-3 immu-
nostaining of tracheal epithelial cells representing late
stage apoptosis [18] was most evident after 48 h of
culture.
One of the distinctive features of the asthmatic air-
ways is mucus hypersecretion, associated with goblet
A      C 
Mast cells    Eosinophils 
B      D 
 Control 
 Allergic 
Figure 4 Immunostaining for mast cells and eosinophils in tracheal explants. Mast cell (tryptase+) staining in (A) control and (B) allergic
tissues, and eosinophil (galectin-14+) staining in (C) control and (D) allergic tracheal explants. Note the increased number of immunopositive
mast cells and eosinophils in the allergic (indicated by arrows in B and D) compared to the control tracheal explants (original magnification
×200).
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cell hyperplasia and hypertrophy [3]. In this study, num-
bers of mucus-containing (AB/PAS positive) goblet cells
in the tracheal epithelium of allergic sheep was similar
compared to control sheep. Following 24 h in culture,
lower numbers of goblet cells were observed in both
allergic and control tissue, although this difference was
significant only in the allergic tissues. This rapid decline
is indicative of the release of mucus or a shutdown in
mucus production and suggests that allergic tissue is
particularly sensitive to the release of mucus.
Alternatively, it is possible this may represent part of a
stress response in vivo [22]. While there was a loss of
goblet cell staining in culture, the effects of tissue pro-
cessing for histological analyses most likely resulted in
the loss of the mucus layer overlying the epithelium.
Mast cells are required for the development of allergic
reactions, with cross-linking of the high affinity recep-
tors for IgE resulting in degranulation and release of
cytokines. This cross-linking is generally achieved by
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Figure 5 Quantitation of mast cells and eosinophils in control and allergic tracheal explants. Mean (± SEM) number of (A) mast cell and
(B) eosinophil counts per mm2 lamina propria in tracheal explants from control and allergic tissues prior to culture (0 h) or following 24 h
culture in the presence of media alone or HDM. (* denotes statistical significance, p < 0.05, ***p < 0.001; Kruskal-Wallis for within-group
comparisons; Mann-Whitney for allergic vs control).
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the mast cells. Studies have shown increased mast cells
within sheep alveolar septa and airway walls following
chronic airway allergen (HDM) challenge [23]. In the
present study mast cells were abundant in all tracheal
tissues at 0 h, while there was a significant decline in
mast cell numbers following culture in medium alone or
in the presence of HDM in the allergic but not control
tissues. Together with the more dramatic decline in
goblet cells in the allergic tissue this may reflect the
hypersensitive nature of the allergic explants. Further to
this, mast cell staining in all tracheal explants from
allergic tissue showed larger, diffusely-stained cells indi-
cative of degranulating mast cells, compared to the
smaller stained cells seen in control tissues. That HDM
had no impact on mast cell numbers in either allergic
or control explants is an intriguing observation but not
unlike what we have previously observed in allergen-
challenged dermal tissue [17]. It is possible that HDM
allergens have an impact on other mast cell related
activities, not examined in the present study, such as
release of cytokines [24,25].
Airway eosinophilia is a central component of asthma
pathogenesis. Upon recruitment to the airways, eosino-
phil activation results in the release of mediators and
toxic granule proteins, the actions of which include
epithelial damage and stimulation of mucus secretion
[26,27]. In previous studies we reported a 4 to 6-fold
increase in eosinophils in the lungs of HDM challenged
sheep compared to control tissue [14]. In the present
study, an approximate 5-fold increase in (galectin-14
positive) eosinophils was seen in allergic compared to
control tissues. Increased galectin-14 has also been
demonstrated by Western blot analyses in BAL fluid fol-
lowing airway allergen challenge in allergic sheep [20].
The secretion of the cytokines IL-6, TNF-a and IL-1a
in the tracheal explant cultures was assessed by ELISA,
and while TNF-a and IL-1a were undetected, detectable
levels of IL-6 were released by allergic tissues but absent
in control tissues. A previous study of IL-6 mRNA
expression in human airway epithelial cells observed
very low or no IL-6 levels in non-asthmatic tissue com-
pared to asthmatic tissue [28]. IL-6 levels are signifi-
cantly increased in asymptomatic asthmatic patients
compared to control patients, as well as during naturally
occurring asthma attacks [29], indicating involvement of
IL-6 in asthma pathogenesis. Upregulation of IL-6 is
also detected within airway epithelial cells in sympto-
matic asthma patients [28]. TNF-a and IL-1a on the
other hand are predominantly produced in respiratory
mucosa by tissue macrophages, perhaps explaining why
they were undetected in the washout samples. Further-
more, cytokines released by the epithelium may be
trapped in the mucus layer or may not be released
apically.
Animal experimental models have proven to be
imperative in understanding disease processes and
recent research has focused in particular on the inflam-
matory mediators in the airways, in the hope of develop-
ing more specific and effective therapeutic avenues for
asthma treatment. This study examined a tracheal tissue
explant model as an investigative tool in asthma
research. A distinct advantage of this explant model,
compared to other in vitro models, is the preservation
of the tissue architecture and microenvironment that
may better reflect conditions and effects encountered in
vivo. The present studies suggest this tracheal explant
model may be most relevant for investigations over
shorter culture periods (< 24 h), since tissue changes
became more evident over longer periods in culture. As
allergen stimulation causes an immediate hypersensitiv-
ity response in asthmatic subjects following degranula-
tion of mast cells and release of inflammatory
mediators, it would be interesting to examine in more
detail the early time points after HDM challenge of tis-
sue explants and measure the release of these mediators
during this period in both allergic and non-allergic
explants. Using a validated large animal model with
similar airway structures to human, the tracheal explant
model offers great potential for studying the complex
mechanisms driving allergic disease and could be used
as a platform for the screening of potential anti-asthma
therapeutics.
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